Finding drugs that slow aging and extend healthy life
Drug Targeting, Testing, and Development
['FUNDING_OTHER'] · TRANSLATIONAL GENOMICS RESEARCH INST · NIH-11195712
This project looks for medicines that may slow aging and help adults stay healthier longer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TRANSLATIONAL GENOMICS RESEARCH INST (nih funded) |
| Locations | 1 site (PHOENIX, UNITED STATES) |
| Trial ID | NIH-11195712 on ClinicalTrials.gov |
What this research studies
The team uses computer chemistry tools to pick drug candidates and likely targets linked to aging. Promising drugs are tested in mice using molecular "Aging Rate Indicators" measured in blood, fat, muscle, liver, and brain to see if they slow age-related changes. The project also includes early, exploratory work in humans and pet dogs and draws on public data to guide choices. If you join, researchers may ask for blood samples, biopsies, or other tissue samples depending on the part of the project.
Who could benefit from this research
Good fit: Ideal candidates are adults (often middle-aged or older) willing to provide blood or tissue samples and possibly participate in early human trials.
Not a fit: People under 21, those unwilling to give samples or undergo biopsies, and individuals seeking immediate treatment for a specific disease are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, this work could lead to medicines that delay age-related decline and increase healthy years of life.
How similar studies have performed: Related laboratory and mouse studies have found aging markers and some drugs that slow aging in animals, but human testing remains early and limited.
Where this research is happening
PHOENIX, UNITED STATES
- TRANSLATIONAL GENOMICS RESEARCH INST — PHOENIX, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MILLER, RICHARD A — TRANSLATIONAL GENOMICS RESEARCH INST
- Study coordinator: MILLER, RICHARD A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.